(Q48719424)

English

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

scientific article published in May 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

K G Nicholson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Y Aoki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A D Osterhaus

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Trottier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

O Carewicz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C H Mercier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Rode

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N Kinnersley

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

355

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9218

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1845-1850

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Economic impact of influenza. The individual's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Health impact of influenza in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of antivirals in influenza in the elderly: prophylaxis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of influenza B virus infection on human performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02288-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

release_w2qeak6fu5cndephgnceirpicq

1 reference

https://api.fatcat.wiki/v0/release/w2qeak6fu5cndephgnceirpicq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48719424&oldid=1835735975"